Reverse Transcriptase Inhibitors in Aicardi Goutieres Syndrome
Latest Information Update: 29 Jul 2024
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
- Indications Congenital abnormalities; Hepatitis B; HIV infections; Primary biliary cirrhosis
- Focus Pharmacodynamics
- Acronyms RTIAGS
- 24 Jul 2024 Planned End Date changed from 1 Dec 2028 to 1 Dec 2029.
- 24 Jul 2024 Planned primary completion date changed from 1 Dec 2028 to 1 Dec 2029.
- 24 Jul 2024 Planned initiation date changed from 1 Dec 2024 to 1 Dec 2025.